c61190sc13da2.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13D/A
(Amendment No.
2)
Under
the Securities Exchange Act of 1934
BIOANALYTICAL
SYSTEMS INC
|
(Name
of Issuer)
|
Common
Stock
|
(Title
of Class of Securities)
|
09058M-10-3
THOMAS A
HARENBURG
206 N
MAIN ST. PO BOX 1069
OSHKOSH
WI 54903
|
(Name,
Address and Telephone Number of Person
Authorized
to Receive Notices and Communications)
|
June
11, 2009
|
(Date
of Event which Requires
Filing
of this Statement)
|
If the
filing person has previously filed a statement on Schedule 13G to report the
acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box x
*The
remainder of this cover page shall be filled out for a reporting person’s
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The
information required on the remainder of this cover page shall not be deemed to
be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the
Notes).
SCHEDULE
13D/A
CUSIP
No.
|
09058M-10-3
|
|
Page
2 of 5 Pages
|
1
|
NAME
OF REPORTING PERSON
I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
|
THOMAS
A
HARENBURG
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE
INSTRUCTIONS)
|
(a)
|
|
|
|
(b)
|
|
3
|
SEC
USE ONLY
|
4
|
SOURCE
OF FUNDS (SEE INSTRUCTIONS)
|
INVESTMENT
FUNDS
|
5
|
CHECK
IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d)
OR 2(e)
|
o
|
|
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
|
US
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE
VOTING POWER
|
155,307
|
8
|
SHARED
VOTING POWER
|
121,460
|
9
|
SOLE
DISPOSITIVE POWER
|
155,307
|
10
|
SHARED
DISPOSITIVE POWER
|
121,460
|
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
276,767
|
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
|
|
(SEE
INSTRUCTIONS)
|
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
5.63%
|
14
|
TYPE
OF REPORTING PERSON
|
INDIVIDUAL
INVESTOR
|
Page 3 of
5
Item
1. Security and
Issuer.
This
statement on Schedule 13D (“Schedule 13D”) relates to 276,767 shares of common
stock, of BIOANALYTICAL SYSTEMS AN INDIANA corporation (the “Issuer”), whose
principal executive offices are located at 2701 KENT AVE., WEST LAFAYETTE, IN
47906.
Item
2. Identity and
Background.
(a) This
Schedule 13D is filed by THOMAS A HARENBURG who is referred to herein as the
“Reporting Person.”
(b) The
Reporting Person’s business address is 206 N MAIN ST., OSHKOSH, WI
54901.
(c)
Mr. HARENBURG IS THE PRESIDENT OF CARL M HENNIG
Inc.
(d) During
the last five years, the Reporting Person has not been convicted in a criminal
proceeding (excluding traffic violations or similar misdemeanors).
(e) During
the last five years, the Reporting Person has not been a party to any other
civil proceeding of a judicial or administrative body of competent jurisdiction
and as a result of such proceeding was or is subject to a judgment, decree or
final order enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or finding any violation
with respect to such laws.
(f) United
States of America.
Item
3.
Source and
Amount of Funds or Other Consideration.
INVESTMENT FUNDS
Item
4. Purpose of
Transaction.
REQUESTING BOARD REPRESENTATION 1 OF 5 EXISTING SEATS
Page 4 of
5
Item
5. Interest in Securities of
the Issuer.
(a) The
Reporting Person may be deemed to be the beneficial owner of 276,767 shares of
Common Stock. Such 276,767 shares represent approximately 5.63% of
the outstanding shares of Common Stock.
(b) The
Reporting Person has the sole power to vote or to direct the vote or to dispose
or to direct the disposition of 155,307 shares.
(c) The
Reporting Person received all of shares in the issuer pursuant to the conversion
of stock options.
(d) Not
applicable.
(e) Not
applicable.
Item
6.
Contracts, Arrangements,
Understandings or Relationships with Respect to Securities of the
Issuer.
Not
applicable.
Item
7. Material to be Filed as
Exhibits.
Exhibit
99.2 - Letter to the Board of Directors of Bioanalytical
Systems
Page 5 of
5
Signatures
After
reasonable inquiry and to the best of the knowledge and belief of the
undersigned, each of the undersigned certifies that the information set forth in
this statement is true, complete and correct.
Dated: June
11, 2009
|
|
|
|
|
|
/s/ THOMAS
A HARENBURG |
|
|
|
THOMAS
A HARENBURG |
|
|
|
|
|
|
|
|
|